

Novo Nordisk CEO Talks Weight Loss Drug Supply
May 2, 2024
Novo Nordisk CEO discusses scaling up production of weight-loss drug Wegovy with Bloomberg journalists. Topics include manufacturing capacity, unit costs, pricing strategies in drug production, long-term use of weight loss drugs, administration routes, and personalized medicine.
Chapters
Transcript
Episode notes